基于患者报告结局的远程监测与预警干预用于关节置换术后关键恢复路径早期检测的成本效果:一项随机对照试验
该成本效果分析基于在9家德国医院纳入的3697例髋关节置换和3110例膝关节置换患者的多中心随机对照试验,其中546例髋和492例膝置换病例有来自24家法定医疗保险的纵向成本数据。干预组在术后1、3、6个月额外接受基于患者报告结局的远程监测,出现关键恢复路径时予以联系。髋置换患者干预组PRO-CM改善2.54单位且费用减少376.43€,呈优势ICER;膝置换患者效果与费用差异均未达统计学显著。
要点
- 髋置换患者干预组PRO-CM提高2.54单位(95%CI [0.93, 4.14];p=0.002),费用减少376.43€(95%CI [-639.74, -113.12];p=0.005),呈优势ICER。
- 膝置换患者干预组PRO-CM变化0.87(95%CI [-0.94, 2.67];p=0.347),费用减少375.50€(95%CI [-767.40, 16.39];p=0.060),均未达统计学显著。
- 尚不清楚多阶段干预中哪一步对阳性效果贡献最大。
核心结论
- 与标准护理相比,该干预显著改善髋置换患者的结局且费用更低;在膝置换患者中显示费用降低但未达统计学显著。
研究设计与样本
- 成本效果分析基于一项多中心随机对照试验,2019至2020年在9家德国医院纳入3697例髋置换和3110例膝置换患者。
- 分析纳入546例髋置换和492例膝置换病例,均有来自24家法定医疗保险的纵向成本数据。
- 患者按1:1随机分配至基于患者报告结局的远程监测与预警干预组或标准护理组,所有患者在术后12个月通过数字化采集的患者报告结局进行评估。
主要发现
- 髋置换患者干预组PRO-CM改善2.54单位(95%CI [0.93, 4.14];p=0.002),膝置换患者干预组PRO-CM变化0.87(95%CI [-0.94, 2.67];p=0.347)。
- 术后12个月内,髋置换患者干预组费用减少376.43€(95%CI [-639.74, -113.12];p=0.005),膝置换患者干预组费用减少375.50€(95%CI [-767.40, 16.39];p=0.060)。
- 两种手术均显示优势ICER。
- 尚不清楚多阶段干预中哪一步对阳性效果贡献最大。
关键数值与推荐
- PRO-CM为基于患者报告结局的复合指标,将多个患者报告结局量表的变化合并为0至100的单一指数,包含6个聚焦生活质量及躯体与心理健康各方面的患者报告结局量表。
- 主要结局为增量成本效果比(ICER)。
临床怎么用
- 作者认为,该结果强化了患者报告结局可在标准护理环境中作为远程监测的成本有效工具这一观点。
局限性
- 尚不清楚多阶段干预中哪一步对阳性效果贡献最大。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: While the effectiveness of patient-reported outcome measures (PROMs) as an intervention to impact patient pathways has been established for cancer care, it is unknown for other indications. We assessed the cost-effectiveness of a PROM-based monitoring and alert intervention for early detection of critical recovery paths following hip and knee replacement. METHODS AND FINDINGS: The cost-effectiveness analysis (CEA) is based on a multicentre randomised controlled trial encompassing 3,697 patients with hip replacement and 3,110 patients with knee replacement enrolled from 2019 to 2020 in 9 German hospitals. The analysis was conducted with a subset of 546 hip and 492 knee replacement cases with longitudinal cost data from 24 statutory health insurances. Patients were randomised 1:1 to a PROM-based remote monitoring and alert intervention or to a standard care group. All patients were assessed at 12-months post-surgery via digitally collected PROMs. Patients within the intervention group were additionally assessed at 1-, 3-, and 6-months post-surgery to be contacted in case of critical recovery paths. For the effect evaluation, a PROM-based composite measure (PRO-CM) was developed, combining changes across various PROMs in a single index ranging from 0 to 100. The PRO-CM included 6 PROMs focused on quality of life and various aspects of physical and mental health. The primary outcome was the incremental cost-effectiveness ratio (ICER). The intervention group showed incremental outcomes of 2.54 units PRO-CM (95% confidence interval (CI) [0.93, 4.14]; p = 0.002) for patients with hip and 0.87 (95% CI [-0.94, 2.67]; p = 0.347) for patients with knee replacement. Within the 12-months post-surgery period the intervention group had less costs of 376.43€ (95% CI [-639.74, -113.12]; p = 0.005) in patients with hip, and 375.50€ (95% CI [-767.40, 16.39]; p = 0.060) in patients with knee replacement, revealing a dominant ICER for both procedures. However, it remains unclear which step of the multistage intervention contributes most to the positive effect. CONCLUSIONS: The intervention significantly improved patient outcomes at lower costs in patients with hip replacements when compared with standard care. Further it showed a nonsignificant cost reduction in knee replacement patients. This reinforces the notion that PROMs can be utilised as a cost-effective instrument for remote monitoring in standard care settings. TRIAL REGISTRATION: Registration: German Register for Clinical Studies (DRKS) under DRKS00019916.
引用
- Schöner L, Kuklinski D, Wittich L, et al. Cost-effectiveness of a patient-reported outcome-based remote monitoring and alert intervention for early detection of critical recovery after joint replacement: A randomised controlled trial. PLoS Med. 2024. PMID: 39383175. doi:10.1371/journal.pmed.1004459
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。